Relationship Between RUNX3,cyclin E,P21 and Survival in Gastric Cancer Patients

CHEN Jin-ming,GAN Jian-xin,YU Chun-zhao,WANG Shen-hua,WU Jun-song,YI Jian-hua,YANG Jian-xin,ZHOU Hai-bo
DOI: https://doi.org/10.3321/j.issn:1000-4718.2006.09.023
2006-01-01
Abstract:AIM:To evaluate the relationship between RUNX3,cyclin E,P21,biological features and survival in gastric cancer patients.METHODS:RUNX3 was examined using immunohistochemical staining.Cyclin E and P21 were analyzed by flow cytometry.Survival was evaluated by Kaplan-Meier survival curves.RESULTS:The positive-expression rate of RUNX3,cyclin E and P21 in tumor tissue from 56 patients with gastric cancer were 44.6%,64.3% and 32.1%,respectively.RUNX3 expression was correlated with lymph node metastasis and distant metastasis(P0.05).Cyclin E might be related to depth of invasion,lymph node metastasis and distant metastasis(P0.05).P21 was correlated with lymph node metastasis(P0.05).It was revealed that RUNX3 and P21 were correlated(r=0.57,P0.05),no correlation between RUNX3 and cyclin E was observed(r=0.25,P0.05).Using Kaplan-Meier survival curves and the Log-rank test,there was correlation between RUNX3,cyclin E and survival(P0.05).No correlation between P21 and survival was observed(P0.05).CONCLUSION:RUNX3 may be related with tumorigenesis and tumor progression by affecting P21 expression.The detection of RUNX3 and cyclin E may be helpful in evaluating the clinicopathological parameters and prognosis in gastric carcinoma patients.
What problem does this paper attempt to address?